Literature DB >> 23291454

High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system.

D F Martins1, L Mazzardo-Martins, F Soldi, J Stramosk, A P Piovezan, A R S Santos.   

Abstract

This study investigated the involvement of the adenosinergic system in antiallodynia induced by exercise in an animal model of complex regional pain syndrome type I (CRPS-I). Furthermore, we analyzed the role of the opioid receptors on exercise-induced analgesia. Ischemia/reperfusion (IR) mice, nonexercised and exercised, received intraperitoneal injections of caffeine (10mg/kg, a non selective adenosine receptor antagonist), 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (0.1mg/kg, a selective adenosine A receptor antagonist), ZM241385 (3mg/kg, a selective adenosine A receptor antagonist), adenosine deaminase inhibitor erythro-9-(2-hydroxy-3nonyl) adenine [(EHNA), 5mg/kg, an adenosine deaminase inhibitor] or naloxone (1mg/kg, a nonselective opioid receptor antagonist). The results showed that high-intensity swimming exercise reduced mechanical allodynia in an animal model of CRPS-I in mice. The antiallodynic effect caused by exercise was reversed by pretreatment with caffeine, naloxone, DPCPX but it was not modified by ZM241385 treatment. In addition, treatment with EHNA, which suppresses the breakdown of adenosine to inosine, enhanced the pain-relieving effects of the high-intensity swimming exercise. This is the first report demonstrating that repeated sessions of high-intensity swimming exercise attenuate mechanical allodynia in an animal model of CRPS-I and that the mechanism involves endogenous adenosine and adenosine A receptors. This study supports the use of high-intensity exercise as an adjunct therapy for CRPS-I treatment.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291454     DOI: 10.1016/j.neuroscience.2012.12.042

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

Review 1.  Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions.

Authors:  Bing-Xin Sun; Ai-Shi Peng; Pei-Jie Liu; Min-Jia Wang; Hai-Li Ding; Yu-Shi Hu; Liang Kang
Journal:  Purinergic Signal       Date:  2022-07-11       Impact factor: 3.950

2.  High-Intensity Swimming Exercise Decreases Glutamate-Induced Nociception by Activation of G-Protein-Coupled Receptors Inhibiting Phosphorylated Protein Kinase A.

Authors:  Daniel F Martins; Aline Siteneski; Daniela D Ludtke; Daniela Dal-Secco; Adair R S Santos
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

3.  The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.

Authors:  Manuella P Kaster; Josiane Budni; Marta Gazal; Mauricio P Cunha; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2013-04-25       Impact factor: 3.765

Review 4.  Ketogenic diets and pain.

Authors:  Susan A Masino; David N Ruskin
Journal:  J Child Neurol       Date:  2013-05-16       Impact factor: 1.987

5.  Bradykinin Receptors Play a Critical Role in the Chronic Post-ischaemia Pain Model.

Authors:  Elaine C D Gonçalves; Graziela Vieira; Tainara R Gonçalves; Róli R Simões; Indiara Brusco; Sara M Oliveira; João B Calixto; Maíra Cola; Adair R S Santos; Rafael C Dutra
Journal:  Cell Mol Neurobiol       Date:  2020-03-28       Impact factor: 5.046

6.  A forced running wheel system with a microcontroller that provides high-intensity exercise training in an animal ischemic stroke model.

Authors:  C C Chen; M W Chang; C P Chang; S C Chan; W Y Chang; C L Yang; M T Lin
Journal:  Braz J Med Biol Res       Date:  2014-08-15       Impact factor: 2.590

7.  Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System.

Authors:  Eveline Dischkaln Stolz; Paola Fontoura da Costa; Liciane Fernandes Medeiros; Andressa Souza; Ana Maria Oliveira Battastini; Gilsane Lino von Poser; Carla Bonan; Iraci L S Torres; Stela Maris Kuze Rates
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-21       Impact factor: 2.629

Review 8.  The Rationale for Exercise in the Management of Pain in Parkinson's Disease.

Authors:  Natalie E Allen; Niamh Moloney; Vanessa van Vliet; Colleen G Canning
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 9.  Emerging Relationships between Exercise, Sensory Nerves, and Neuropathic Pain.

Authors:  Michael A Cooper; Patricia M Kluding; Douglas E Wright
Journal:  Front Neurosci       Date:  2016-08-23       Impact factor: 4.677

10.  Regular physical activity prevents development of chronic muscle pain through modulation of supraspinal opioid and serotonergic mechanisms.

Authors:  Renan G Brito; Lynn A Rasmussen; Kathleen A Sluka
Journal:  Pain Rep       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.